|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online November 10, 2005
doi: 10.1242/10.1242/dev.02086
1 Department of Pediatrics (Cardiology), Baylor College of Medicine, Houston, TX
77030, USA
2 Program in Cardiovascular Sciences, Baylor College of Medicine, Houston, TX
77030, USA
3 Department of Biochemistry and Molecular Biology, MD Anderson Cancer Center
and Program in Genes and Development, Graduate School of Biomedical Sciences,
University of Texas, Houston, TX 77030, USA
4 Alkek Institute of Biosciences and Technology, Texas A and M System Health
Science Center, Houston, TX 77030, USA
5 Center for Cardiovascular Development, Baylor College of Medicine, Houston, TX
77030, USA
6 Department of Human and Molecular Genetics, Baylor College of Medicine,
Houston, TX 77030, USA
7 CEINGE Biotecnologie Avanzate S.C. ar. I., via Communale Margherita,
482-80145, Naples, Italy
8 Division of Cardiology, Second University of Naples, Naples, Italy
* Author for correspondence (e-mail: elindsay{at}bcm.tmc.edu)
Accepted 13 September 2005
During embryonic life, the initially paired pharyngeal arch arteries (PAAs) follow a precisely orchestrated program of persistence and regression that leads to the formation of the mature aortic arch and great vessels. When this program fails, specific cardiovascular defects arise that may be life threatening or mild, according to the identity of the affected artery. Fourth PAA-derived cardiovascular defects occur commonly in DiGeorge syndrome and velocardiofacial syndrome (22q11DS), and in Tbx1+/ mice that model the 22q11DS cardiovascular phenotype. Tbx1 is expressed in pharyngeal mesoderm, endoderm and ectoderm, and, in addition, we show that it is expressed in precursors of the endothelial cells that line the PAAs, thus expanding the number of tissues in which Tbx1 is potentially required for fourth PAA development. In this study, we have used cell fate mapping and tissue-specific gene deletion, driven by six different Cre lines, to explore Tbx1 gene-dosage requirements in the embryonic pharynx for fourth PAA development. Through this approach, we have resolved the spatial requirements for Tbx1 in this process, and we show pharyngeal epithelia to be a critical tissue. We also thereby demonstrate conclusively that the role of Tbx1 in fourth PAA development is cell non-autonomous.
Key words: Tbx1, DiGeorge syndrome, 22q11DS, Pharyngeal epithelia, Mouse
This article has been cited by other articles:
![]() |
K. Stankunas, C. Shang, K. Y. Twu, S.-C. Kao, N. A. Jenkins, N. G. Copeland, M. Sanyal, L. Selleri, M. L. Cleary, and C.-P. Chang Pbx/Meis Deficiencies Demonstrate Multigenetic Origins of Congenital Heart Disease Circ. Res., September 26, 2008; 103(7): 702 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. MacDonald, S. D. Bamforth, C.-M. Chen, C. R. Farthing, A. Franklyn, C. Broadbent, J. E. Schneider, Y. Saga, M. Lewandoski, and S. Bhattacharya Epiblastic Cited2 deficiency results in cardiac phenotypic heterogeneity and provides a mechanism for haploinsufficiency Cardiovasc Res, August 1, 2008; 79(3): 448 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Hakim, L. A. DiMichele, J. T. Doherty, J. W. Homeister, H. E. Beggs, L. F. Reichardt, R. J. Schwartz, J. Brackhan, O. Smithies, C. P. Mack, et al. Conditional Deletion of Focal Adhesion Kinase Leads to Defects in Ventricular Septation and Outflow Tract Alignment Mol. Cell. Biol., August 1, 2007; 27(15): 5352 - 5364. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fagman, J. Liao, J. Westerlund, L. Andersson, B.E. Morrow, and M. Nilsson The 22q11 deletion syndrome candidate gene Tbx1 determines thyroid size and positioning Hum. Mol. Genet., February 1, 2007; 16(3): 276 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, T. Huynh, and A. Baldini Mesodermal expression of Tbx1 is necessary and sufficient for pharyngeal arch and cardiac outflow tract development Development, September 15, 2006; 133(18): 3587 - 3595. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Park, L. A. Ogden, A. Talbot, S. Evans, C.-L. Cai, B. L. Black, D. U. Frank, and A. M. Moon Required, tissue-specific roles for Fgf8 in outflow tract formation and remodeling Development, June 15, 2006; 133(12): 2419 - 2433. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Arnold, E. M. Braunstein, T. Ohyama, A. K. Groves, J. C. Adams, M. C. Brown, and B. E. Morrow Tissue-specific roles of Tbx1 in the development of the outer, middle and inner ear, defective in 22q11DS patients Hum. Mol. Genet., May 15, 2006; 15(10): 1629 - 1639. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Arnold, U. Werling, E. M. Braunstein, J. Liao, S. Nowotschin, W. Edelmann, J. M. Hebert, and B. E. Morrow Inactivation of Tbx1 in the pharyngeal endoderm results in 22q11DS malformations Development, March 1, 2006; 133(5): 977 - 987. [Abstract] [Full Text] [PDF] |
||||